NDC 0404-9888
Lidocaine Hydrochloride 10 mg per 1 mL injection, solution
On the label: Henry Schein, Inc.. It's repackaged: Henry Schein, Inc. rebottles it from Hospira, Inc.'s NDC 0409-4276.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
| Pfizer Healthcare India Private Limited | Anakapalli, India | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyOct 18, 2022 · 7 inspections, 1 with FDA action |
| Hospira, Inc. | McPherson, KS, United States | Tests it | Problems found, fixed voluntarilyJan 17, 2025 · 16 inspections, 2 with FDA action |
Recalls
- Sep 16, 2013 · Class I · Hospira, Inc.
Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP.
Lots: Lot #25090DK; Exp 01/15
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Lidocaine: every company that makes it
- Form
- injection, solution, infiltration; perineural
- Strength
- 10 mg per 1 mL
- Approval
- ANDA ANDA088299
- On the market since
- Jan 12, 2022
- Package NDCs
0404-9888-200404-9888-50- Official label
- DailyMed (National Library of Medicine), updated Sep 14, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?